The circulating proteomic signature of alcohol-associated liver disease
Despite being a leading cause of advanced liver disease, alcohol-associated liver disease (ALD) has no effective medical therapies. The circulating proteome, which comprises proteins secreted by different cells and tissues in the context of normal physiological function or in the setting of disease...
Main Authors: | Jay Luther, Augustin G.L. Vannier, Esperance A. Schaefer, Russell P. Goodman |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2022-07-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.159775 |
Similar Items
-
Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans
by: Tatsunori Miyata, et al.
Published: (2021-02-01) -
The role of SHP/REV-ERBα/CYP4A axis in the pathogenesis of alcohol-associated liver disease
by: Zhihong Yang, et al.
Published: (2021-08-01) -
Substance Use Disorder Is Associated With Alcohol-Associated Liver Disease in Patients With Alcohol Use Disorder
by: Augustin G.L. Vannier, et al.
Published: (2022-01-01) -
Preventive hepatology: An ounce of prevention or pounds of cure to curb liver diseases
by: Ajeet S. Bhadoria, et al.
Published: (2023-03-01) -
Genetics in liver disease /
by: Blum, H. E.
Published: (2007)